These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Tseng WW; Swallow CJ; Strauss DC; Bonvalot S; Rutkowski P; Ford SJ; Gonzalez RJ; Gladdy RA; Gyorki DE; Fairweather M; Lee KW; Albertsmeier M; van Houdt WJ; Fau M; Nessim C; Grignani G; Cardona K; Quagliuolo V; Grignol V; Farma JM; Pennacchioli E; Fiore M; Hayes A; Tzanis D; Skoczylas J; Almond ML; Mullinax JE; Johnston W; Snow H; Haas RL; Callegaro D; Smith MJ; Bouhadiba T; Desai A; Voss R; Sanfilippo R; Jones RL; Baldini EH; Wagner AJ; Catton CN; Stacchiotti S; Thway K; Roland CL; Raut CP; Gronchi A; Ann Surg Oncol; 2022 Nov; 29(12):7335-7348. PubMed ID: 35767103 [TBL] [Abstract][Full Text] [Related]
29. Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma. Hager S; Makowiec F; Henne K; Hopt UT; Wittel UA Radiat Oncol; 2017 Jan; 12(1):29. PubMed ID: 28126006 [TBL] [Abstract][Full Text] [Related]
30. Prognostic Factors and Nomogram Construction for First Local Recurrent Retroperitoneal Sarcoma Following Surgical Resection: A Single Asian Cohort of 169 Cases. Zhuang A; Lu W; Fang Y; Ma L; Xu J; Wang J; Tong H; Zhang Y Front Oncol; 2022; 12():856754. PubMed ID: 35480122 [TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis. Nizri E; Fiore M; Barretta F; Colombo C; Radaelli S; Callegaro D; Sanfilippo R; Sangalli C; Collini P; Stacchiotti S; Casali PG; Miceli R; Gronchi A Ann Surg Oncol; 2019 Oct; 26(11):3535-3541. PubMed ID: 31313035 [TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Youssef E; Fontanesi J; Mott M; Kraut M; Lucas D; Mekhael H; Ben-Josef E Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):514-9. PubMed ID: 12243830 [TBL] [Abstract][Full Text] [Related]
33. Prognostic factors of primary resected retroperitoneal soft tissue sarcoma: Analysis from a single asian tertiary center and external validation of gronchi's nomogram. Chou YS; Liu CY; Chang YH; King KL; Chen PC; Pan CC; Shen SH; Liu YM; Lin AT; Chen KK; Shyr YM; Lee RC; Chao TC; Yang MH; Chan CH; You JY; Yen CC J Surg Oncol; 2016 Mar; 113(4):355-60. PubMed ID: 26749009 [TBL] [Abstract][Full Text] [Related]
34. Outcome of iliocaval resection and reconstruction for retroperitoneal sarcoma. Ferraris M; Callegaro D; Barretta F; Fiore M; Radaelli S; Stacchiotti S; Miceli R; Socrate AM; Locati P; Gronchi A J Vasc Surg Venous Lymphat Disord; 2019 Jul; 7(4):547-556. PubMed ID: 30792153 [TBL] [Abstract][Full Text] [Related]
35. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860 [TBL] [Abstract][Full Text] [Related]
36. Applicability of the Sarculator and MSKCC nomograms to retroperitoneal sarcoma prognostication in an Asian tertiary center. Wong RX; Koh YS; Ong F; Farid M; Tay TKY; Teo M Asian J Surg; 2020 Nov; 43(11):1078-1085. PubMed ID: 31941593 [TBL] [Abstract][Full Text] [Related]
37. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana. Erzen D; Sencar M; Novak J J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353 [TBL] [Abstract][Full Text] [Related]
38. Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre. Snow HA; Hitchen TX; Head J; Herschtal A; Bae S; Chander S; Chu J; Hendry S; Ngan SY; Desai J; Choong PFM; Henderson M; Gyorki DE ANZ J Surg; 2018 Nov; 88(11):1151-1157. PubMed ID: 30288891 [TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant radiotherapy followed by surgery compared with surgery alone in the treatment of retroperitoneal sarcoma: a population-based comparison. Turner BT; Hampton L; Schiller D; Mack LA; Robertson-More C; Li H; Quan ML; Bouchard-Fortier A Curr Oncol; 2019 Dec; 26(6):e766-e772. PubMed ID: 31896947 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients. Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]